Please login to the form below

Not currently logged in
Email:
Password:

e-Therapeutics opens new UK drug discovery centre

Oxford facility will lead company's work in network pharmacology

Newcastle, UK-based e-Therapeutics has opened a new drug discovery facility in Long Hanborough, near Oxford.

The Network Pharmacology Centre will focus on searching for novel treatments for cancer and degenerative diseases of the nervous system.

The Centre was officially declared open by the Prime Minister, David Cameron.

He said: “e-Therapeutics is a fascinating and innovative business in my constituency. Their use of pioneering science has the potential to deliver great results and I very much hope that their treatments are successful.”

Professor Malcolm Young, founder and CEO of e-Therapeutics, said: “We are delighted to have the Prime Minister open our new drug discovery centre near Oxford, which is a world centre of excellence in the science that underpins our business.”

e-Therapeutics says its work in 'network pharmacology', which combines advances in chemical biology and network science, has the potential to produce new and improved treatments for complex diseases.

It involves applying network analysis to determine the set of proteins most critical in any disease, and then using chemical biology techniques to identify molecules capable of targeting that set of proteins.

During 2012 e-Therapeutics plans to advance four drugs derived from network pharmacology research into clinical trials.

These include potential treatments for cancer, major depressive disorder and resistant bacterial infections.

28th February 2012

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

Latest intelligence

How ‘Greenwashing’ accusations could delay the very changes its supporters demand
Are shouts of companies ‘greenwashing’ to provide a façade of environmental and ethical respectability causing more harm than good? Or should we call out practices that we believe are papering...
What does the future hold for clinical trial recruitment?
The past couple of years have raised several aspects of healthcare in the public’s consciousness – and one of the leading ones has been the role of clinical trials in...
When is an agency not an agency?
The PR Week UK Top 150 Consultancies prompts anticipation and curiosity. But can a virtual collective of freelancers fairly be compared and ranked against conventional agencies?...